ProMIS Neurosciences EPS Q / Q
¿Qué es el EPS Q / Q de ProMIS Neurosciences?
El EPS Q / Q de ProMIS Neurosciences, Inc. es 0.00%
¿Cuál es la definición de EPS Q / Q?
La tasa de crecimiento trimestral del EPS, trimestre a trimestre , es el aumento del EPS de la compañía en los últimos 4 trimestres en comparación con el comportamiento de los 4 trimestres anteriores.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q / Q de compañías en Sector Health Care en OTC en comparadas con ProMIS Neurosciences
¿Qué hace ProMIS Neurosciences?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Empresas con eps q / q similar a ProMIS Neurosciences
- Alleghany tiene EPS Q / Q de -0.63%
- Celanese Corp tiene EPS Q / Q de -0.60%
- Walmart Inc tiene EPS Q / Q de -0.56%
- M.D.C tiene EPS Q / Q de -0.50%
- Bristol-Myers Squibb Co tiene EPS Q / Q de -0.50%
- National Bank of Canada tiene EPS Q / Q de -0.42%
- ProMIS Neurosciences tiene EPS Q / Q de 0.00%
- ASML NV tiene EPS Q / Q de 0.70%
- Zebra Technologies tiene EPS Q / Q de 0.88%
- GATX tiene EPS Q / Q de 0.90%
- Washington Trust tiene EPS Q / Q de 0.93%
- Raymond James tiene EPS Q / Q de 0.97%
- ePlus Inc tiene EPS Q / Q de 1.02%